Connection

Kai Deng to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Kai Deng has written about Spike Glycoprotein, Coronavirus.
Kai Deng
Connection Strength
0.056
Spike Glycoprotein, Coronavirus
  1. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cell Mol Immunol. 2020 10; 17(10):1098-1100.
    View in: PubMed
    Score: 0.025
  2. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell Mol Immunol. 2020 06; 17(6):647-649.
    View in: PubMed
    Score: 0.024
  3. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants. J Clin Microbiol. 2021 10 19; 59(11):e0092121.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.